Park Ha Biological Technology BYAH
NASDAQ BYAH
$2.97 +0.04 (+1.37%)
At close: Aug 19, 2026 · 4:00 PM UTC

Park Ha Biological Technology (BYAH) Operating Leases (2023 - 2026)

Park Ha Biological Technology (BYAH) posted quarterly Operating Leases of $57899.0 for Q2 2026, down 23.73% quarter-over-quarter from $75915.0 in Q4 2025.

Park Ha Biological Technology (BYAH) Operating Leases (2023 - 2026) Analysis & Trends

Park Ha Biological Technology's Operating Leases history runs 3 years deep, the most recent figure standing at $57899.0 for Q2 2026.

  • In Q2 2026, Operating Leases changed N/A year-over-year to $57899.0; the TTM figure through Apr 2026 stood at $57899.0 (changed N/A YoY), while the FY2025 annual figure was $75915.0, changed N/A from the prior year.
  • Operating Leases for Q2 2026 stood at $57899.0, down from $75915.0 in the prior quarter.
  • The five-year high for Operating Leases was $75915.0 in Q4 2025, with the low at $9492.0 in Q4 2023.
  • The 3-year median for Operating Leases is $57899.0 (2026), against an average of $47768.7.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Procter & Gamble 334.68 Bn 324.73 Bn 10.28 Bn
2 Unilever 135.06 Bn 122.54 Bn -
3 Colgate Palmolive 73.11 Bn 71.74 Bn 3.30 Bn
4 Kenvue 36.14 Bn 35.03 Bn 2.30 Bn
5 Kimberly Clark 35.84 Bn 34.89 Bn 1.60 Bn
6 Estee Lauder Companies 30.63 Bn 27.51 Bn 2.84 Bn
7 Church & Dwight 23.49 Bn 23.23 Bn 693.90 Mn
8 Clorox 12.90 Bn 12.75 Bn 804.00 Mn
9 Yatsen Holding 5.79 Bn 5.65 Bn 153.20 Mn
10 Park Ha Biological Technology 1.04 Mn -4.62 Mn -

Historic Data

Download Data
DateValue
Apr 30, 2026 57,899.00
Oct 31, 2025 75,915.00
Oct 31, 2023 9,492.00